["{\n\"step_by_step_thinking\": \"The provided documents suggest that platinum-based chemotherapy has improved response rates and prolonged survival for advanced ovarian cancer. Cisplatin is one of the platinum-based chemotherapies mentioned, and it was shown to be as active but less toxic than carboplatin in previously untreated patients with advanced ovarian cancer. However, there are also mentions of cisplatin resistance and the development of new agents to overcome this resistance. No specific information about LB-100 is provided.\",\n\"answer_choice\": \"B: no\"\n}"]